Microbot Medical (MBOT) 25th Annual Needham Virtual Healthcare Conference summary

Market overview and opportunity

• Surgical robotics is a rapidly growing market, with significant interest from both large and small companies.

• The endovascular segment is identified as a 'blue ocean' with minimal competition and high unmet needs.

• The U.S. endovascular market sees 5–6 million procedures annually, making it the second-largest robotics market after laparoscopy.

• There are about 15,000 physicians performing these procedures in 8,000 facilities, with annual healthcare spend exceeding $40 billion.

• Most procedures are life-saving, and 75% of surveyed interventionalists expect robotics integration in their practice.

Barriers and unmet needs

• Major barriers to robotic adoption in endovascular procedures include extended setup time, long learning curves, large equipment footprint, and high capital costs.

• Radiation exposure and ergonomic risks for staff are significant, with increased risks of cataracts, cancer, and musculoskeletal issues.

• Access to quality care remains uneven, especially outside major urban centers.

• Less than 1% of endovascular procedures are currently performed robotically due to these barriers.

LIBERTY system solution

• LIBERTY is a fully disposable, single-use robotic system requiring no capital investment or dedicated infrastructure.

• Setup time is under two minutes, with a short learning curve and compatibility with off-the-shelf guide wires and catheters.

• The system has a small footprint and can be used in any hospital room, eliminating the need for special facilities.

• LIBERTY offers first-mover advantage by removing traditional adoption barriers and providing workflow flexibility.